GDF Antibodies

Santa Cruz Biotechnology features a diverse variety of GDF Antibodies for research focused on understanding growth differentiation factors. GDF Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Growth differentiation factors regulate cellular processes such as differentiation, proliferation, and apoptosis. GDFs are fundamental components in developmental biology and tissue homeostasis, making them essential targets for studying various physiological and pathological conditions. Research involving GDFs has revealed significant implications in cancer development, fibrotic diseases, and cardiovascular disorders. Understanding GDF signaling pathways continues to advance knowledge in regenerative medicine and therapeutic development. Investigating GDF expression patterns helps identify potential therapeutic targets for various diseases. GDF research contributes to understanding organ development and tissue repair mechanisms. Santa Cruz Biotechnology monoclonal antibodies for GDF research support scientists in advancing discoveries that impact human health and disease treatment.